Financials

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
5213
CMND
Clearmind Medicine Inc. - Common Shares
1.99 USD-1.97%-4.78%-42.82%+103.06%31.46 K USD
5246
GMAB
Genmab A/S - American Depositary Shares
28.80 USD-0.69%-0.76%+14.56%+33.64%0 USD
5292
ANL
Adlai Nortye Ltd - American Depositary Shares
9.24 USD-6.38%-16.00%-8.24%+492.31%0 USD
5363
NVO
Novo Nordisk A/S
49.28 USD-0.40%-2.01%+10.22%-29.02%0 USD

Frequently asked questions about Oculis Holding AG - Ordinary shares

What is the Oculis Holding AG - Ordinary shares stock price today?

The current price of Oculis Holding AG - Ordinary shares (OCS) is 13.15. Over the past 24 hours, the stock has changed by -3.52%. Follow the OCS chart for real-time price dynamics.

What is the stock ticker of Oculis Holding AG - Ordinary shares?

Oculis Holding AG - Ordinary shares trades under the ticker OCS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Oculis Holding AG - Ordinary shares stock going up?

OCS has changed by -4.99% over the last week, +14.35% over the last month, and -27.23% over the last year. Review the chart to see whether the current move is part of a broader trend.

How many employees does Oculis Holding AG - Ordinary shares have?

As of the latest available data, Oculis Holding AG - Ordinary shares has 60 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Oculis Holding AG - Ordinary shares stock?

You can buy Oculis Holding AG - Ordinary shares (OCS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Oculis Holding AG - Ordinary shares stock?

Investing in Oculis Holding AG - Ordinary shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the OCS chart and related analysis on metatrader.com as part of your research.

News